Oxford Immunotec Global

$13.70
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.15 (-1.08%) Today
$0.00 (0.00%) As of 8:00 PM EST after-hours

Why Robinhood?

You can buy or sell OXFD and other stocks, options, and ETFs commission-free!

About OXFD

Oxford Immunotec Global Plc operates as a diagnostics company, which develops and commercializes proprietary tests for immunology and infectious disease. Its products include T-SPOT.TB, T-SPOT.CMV, T-SPOT.PRT and T-CELL XTEND. The company was founded by Peter James Wrighton-Smith in 2002 and is headquartered in Abingdon, the United Kingdom. The listed name for OXFD is Oxford Immunotec Global PLC Ordinary Shares.

CEO
Peter James Wrighton-Smith
Employees
243
Headquarters
Abingdon, Oxfordshire
Founded
2013
Market Cap
355.68M
Price-Earnings Ratio
Dividend Yield
Average Volume
66.48K
High Today
$13.99
Low Today
$13.53
Open Price
$13.74
Volume
71.08K
52 Week High
$17.77
52 Week Low
$8.37

Collections

OXFD Earnings

-$0.37
-$0.23
-$0.10
$0.04
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 1, Pre-Market

You May Also Like